Dow Jones Top Company Headlines at 9 AM ET: Trump Threatens Apple With 25% Tariff on Foreign-Made iPhones | Big ... President Trump stepped up pressure on Apple and Chief Executive Tim Cook to make ...

In response to Fitch maintaining Hong Kong's AA- credit rating and stable outlook, the Hong Kong Special Administrative ...

Singapore biotech firm Mirxes began trading in Hong Kong on May 23 at a valuation exceeding US$1 billion. Read more at ...

In the spirit of reconciliation, Australian Associated Press acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our ...

In related news, Singapore-based pharmaceutical company Mirxes, which specializes in cancer treatment, also had a strong debut in Hong Kong on the same day. The company’s shares rose by 28% in morning ...

Lihan Zhou, CEO and Co-Founder of Mirxes, a Singapore-based bio-test company, discusses the company's Hong Kong IPO and ...

Singapore-based cancer diagnostics firm MiRXES has listed on the Hong Kong Stock Exchange, with shares jumping 24.5% above the HKD 23.3 offer price on debut. The stock was trading at HKD 30 as of 3:00 ...

Theodore Shou, CEO of Yiyi Capital, discusses the recent strong performance of the IPO market in Hong Kong and says that the valuation premium between mainland China and Hong Kong stocks would narrow ...

Asian indexes traded higher on Friday as U.S. Treasury yields eased after a rocky week due to worries in the bond market over ...

The Chinese drugmaker raised HK$9.74 billion, equivalent to US$1.25 billion, in net proceeds, making it one of Hong Kong's largest IPOs so far this year. The stock was priced at HK$44.05 per share, ...

Shares of Jiangsu Hengrui Pharmaceuticals soared Friday morning, as more companies seek to tap Hong Kong’s capital markets.

SINGAPORE] If you can’t pull “007” hours or use artificial intelligence (AI) to automate your own role, Aaron Tan, co-founder ...